Articles tagged "Kidney transplantation"

2016 American Transplant Congress
Managing the Kidney Waiting List: Pride and Prejudice.
F. Smith,¹ C. Sheehan,¹ A. Farney,¹ J. Rogers,¹ G. Orlando,¹ A. Reeves-Daniel,² A. Palanisamy,² R. Stratta.¹
¹Surgery, Wake Forest, Winston-Salem, NC; ²Internal Medicine, Wake Forest, Winston-Salem, NC.
Management of the kidney waiting list (WL) is an essential and dynamic aspect of the pretransplant process; however, it remains under-studied and underappreciated. The study…
2016 American Transplant Congress
Ineligible: Attitudes and Follow-Up of Individuals Ruled Out of Living Kidney Donation.
D. Dobosz,¹ C. Thiessen,¹ J. Gannon,¹ S. Li,¹ K. Kennedy,² D. Gray,³ A. Mussell,³ E. Gordon,² S. Kulkarni,¹ P. Reese.³
¹Yale U, New Haven; ²Northwestern U, Chicago; ³U Pennsylvania, Philadelphia.
Background: Little is known about the experiences of individuals who begin living kidney donor (LKD) evaluation but are turned down due to ineligibility. We assessed…
2016 American Transplant Congress
Influence of Cold Ischemia Time in Kidney Transplants from Small Pediatric Donors.
L. Kayler,¹ M. Lubetzky,² P. Friedman.³
¹Erie County Medical Center, Buffalo; ²Montefiore Medical Center, Bronx; ³Montefiore Medical Center, Bronx.
Clinicians may be reluctant to transplant small pediatric kidneys that also have prolonged cold ischemia time (CIT) for fear of an additional deleterious effect since…
2016 American Transplant Congress
Wound Healing Complications in Kidney Transplant Recipients Receiving Everolimus.
P. Ueno,¹ H. Tedesco,¹ A. Brigido,¹ C. Felipe,¹ P. Hannun,¹ M. Cristelli,¹ W. Aguiar,² J. Medina-Pestana.¹
¹Nephrology Division, Hospital do Rim - UNIFESP, Sao Paulo, Brazil; ²Urology Division, Hospital do Rim, Sao Paulo, Brazil.
Background: Regimens with de novo everolimus (EVR) are associated with a concentration-dependent incidence of wound healing adverse events (WHAE), but mycophenolate use also is related…
2016 American Transplant Congress
Factors Affecting Mortality During Waiting Time for Kidney Transplantation: A Nationwide Population-Based Cohort Study Using the Korean Network for Organ Sharing (KONOS) Database.
S. Lee,¹ K. Yoo,² J. An,³ Y. Oh,³ C. Lim,³ Y. Kim,¹ J. Lee.³
¹Seoul National University Hospital, Seoul, Republic of Korea; ²Dongguk University Medical Center, Gyeongju, Republic of Korea; ³Seoul National University Boramae Medical Center, Seoul, Republic of Korea.
Background: Longer waiting times for kidney transplant have been suggested to be more deleterious than shorter waiting times. We analyzed the impact of waiting time…
2016 American Transplant Congress
Influence of Country-Associated Geographical Variables in the Ouctomes of Kidney Transplantation in Patients with HIV-Infection.
M. Cristelli,¹ F. Cofán,² H. Tedesco-Silva,¹ J. Trullas,³ D. Santos,¹ C. Manzardo,⁴ F. Aguero,⁴ A. Moreno,⁴ F. Oppenheimer,² F. Dieckmann,¹ J. Miro,⁴ J. Medina-Pestana.¹
¹Hospital do Rim-UNIFESP, São Paulo, Brazil; ²Nephrology, Hospital Clinic-IDIBAPS, Barcelona, Spain; ³Hospital de Olot, Girona, Spain; ⁴Infectology, Hospital Clinic-IDIBAPS, Barcelona, Spain.
Objective: To evaluate effects of geographical factors on demography, clinical management and evolution of two cohorts of HIV-infected KT recipients.Methods: Observational, retrospective cohort study including…
2016 American Transplant Congress
Outcomes of Second Kidney Transplantation Compared Primary Transplantation According to Donor Specific Antibody.
J. Lee,^1,2 K. Lee,¹ J. Lee,¹ S. Song,¹ J. Lee,¹ S.-K. Kwon,¹ D. Joo,^1,2 K. Huh,^1,2 M. Kim,^1,2 S. Kim,^1,2 Y. Kim.^1,2
¹Department of Surgery, Yonsei University College of Medicine, Seoul, Korea; ²The Research Institute for Transplantation, Yonsei University College of Medicine, Seoul, Korea.
Background:Re-transplantation is associated with an improved overall survival of patients with a failed renal allograft. Some studies showed the outcomes of retransplantation are than those…
2016 American Transplant Congress
Memory Regulatory T Cell: A Potential Actor in Immunological Operational Tolerance in Kidney-Transplant Patients via the ATP Degradation into Adenosine.
M. Durand,^1,2 F. Braza,¹ N. Degauque,¹ F. Dubois,² M. Chesneau,¹ P. Guérif,^1,3 M. Giral,^1,3 S. Brouard.¹
¹ITUN-INSERM U1064, Nantes, France; ²University of Nantes, Nantes, France; ³Biotherapy Clinical Investigation Center, Nantes, France.
Regulatory T cells (Tregs) are essential actors in the control of self-tolerance and exacerbated inflammation. In experimental transplantation Tregs are critical to achieve alloantigen tolerance…
2016 American Transplant Congress
Outcomes in Black vs Non-Black Patients Administered Belatacept (Bela) or Cyclosporine (CsA) in BENEFIT-EXT.
S. Florman,¹ A. Durrbach,² V. Duro Garcia,³ K. Calderon,⁴ U. Meier-Kriesche,⁴ M. Polinsky,⁴ H. Zhao,⁴ J. Medina Pestana.⁵
¹Mount Sinai Med Ctr, New York; ²Univ Hôpital of Bicêtre, Le Kremlin-Bicêtre, France; ³Hosp Dom Vicente Scherer, Porto Alegre, Brazil; ⁴BMS, Lawrenceville; ⁵Hosp do Rim, Sao Paulo, Brazil.
Studies consistently show worse outcomes for black vs non-black kidney transplant recipients. At 7 yrs post-transplant in BENEFIT-EXT (NCT00114777), bela was associated with similar graft…
2016 American Transplant Congress
Alemtuzumab Is Safe and Effective Induction Therapy in Highly Sensitized (HS) Pediatric Patients Undergoing Transplantation.
I. Kim,¹ J. Choi,¹ A. Vo,¹ A. Kang,¹ M. Toyoda,¹ J. Mirocha,² E. Kamil,¹ S. Louie,¹ O. Galera,¹ S. Jordan,¹ D. Puliyanda.¹
¹Comprehensive Transplant Center, Cedars-Sinai Medical Center, Los Angeles, CA; ²Biostatistics Core, Cedars-Sinai Medical Center, Los Angeles, CA.
Introduction: Studies show that alemtuzumab, a potent lymphocyte-depleting agent, is well-tolerated in pediatric renal transplantation. We report on the use of alemtuzumab induction in HS…